Cynthia Kim

机构：Gilead Sciences (United States)

发表论文 13 篇 · 总被引 360 次 · h-index 9

代表论文

• Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine C -Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV (2021 · Journal of Medicinal Chemistry · 被引 90)
• Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells (2021 · Antimicrobial Agents and Chemotherapy · 被引 63)
• Off-Target In Vitro Profiling Demonstrates that Remdesivir Is a Highly Selective Antiviral Agent (2020 · Antimicrobial Agents and Chemotherapy · 被引 57)
• Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection (2021 · Science Translational Medicine · 被引 42)
• Multiplanar MDCT measurement of esophageal hiatus surface area: association with hiatal hernia and GERD (2015 · Surgical Endoscopy · 被引 42)
• Species differences in liver accumulation and metabolism of nucleotide prodrug sofosbuvir (2020 · Drug Metabolism and Pharmacokinetics · 被引 18)